2 Biotechs That Turned $7,000 Into $130,200 for Investors
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"2 Biotechs That Turned $7,000 Into $130,200 for Investors" ALT"2 Biotechs That Turned $7,000 Into $130,200 for Investors"September 29, 2017By Mark Terry, BioSpace.com Breaking News StaffThere... Source: BioSpace
Almirall Discontinues R&D for Two Drugs in the U.S.
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Almirall Discontinues R&D for Two Drugs in the U.S" ALT"Almirall Discontinues R&D for Two Drugs in the U.S"September 29, 2017By Mark Terry, BioSpace.com Breaking News StaffBarcelona, Spain ...…
Merck & Co. Terminates Hep C Development Programs
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-merck.jpg" NAME"Merck & Co. Terminates Hep C Development Programs" ALT"Merck & Co. Terminates Hep C Development Programs"September 29, 2017By Alex Keown, BioSpace.com Breaking News StaffKENILWORTH, N.J. Following... Source: BioSpace
Alere Coughs Up $13 Million to Settle Accounting Fraud Charges With the
Life Sciences Jobs ... Source: BioSpace
DelMar Pharma Announces Fiscal Year 2017 Financial Results
Life Sciences Jobs ... Source: BioSpace
The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam)
Life Sciences Jobs ... Source: BioSpace
<b>MaxWell Biosciences</b> CEO Faces Backlash After Openly Discriminating Against Men
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks3.jpg" NAME"MaxWell Biosciences CEO Faces Backlash After Openly Discriminating Against Men" ALT"MaxWell Biosciences CEO Faces Backlash After Openly Discriminating Against Men"September 27, 2017By Alex Keown, BioSpace... Source: BioSpace
- Go to the previous page
- 1
- …
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- …
- 288
- Go to the next page